Bipolar Disorders Treatment Market, By Drug Class (Mood Stabilizer (Lithium), Antipsychotics (Aripiprazole, Olanzapine, Quetiapine, and Paliperidone), Antidepressants (Citalopram, Escitalopram, Fluoxetine, Paroxetine, and Sertraline), Anticonvulsant (Valproate, Carbamazepine, and Lamotrigine), and Others), by Route of Administration (Oral, Intramuscular, and Intravenous), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and by Region (North America, Europe, Latin America, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

  • To Be Published : Jul 2019 |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Bipolar disorder is related to mental health and can be characterized as drastic changes in mood, energy levels, and ability to perform daily tasks. The mood typically shows two types of episodes – manic and depression. There are four types of bipolar disorders: Bipolar I, Bipolar II, Cyclothymic, and other specified and non-specified bipolar and related disorders. All these types show similar symptoms but the severity varies. Bipolar disorder can be treated with treatments such as mood stabilizers, antipsychotics, antidepressants, and anticonvulsants.

Global Bipolar Disorders Treatment Market Drivers

Key players in the global bipolar disorder treatment market are focusing on research and development of novel drugs that aid in the treatment of bipolar disorders. This in turn is expected to drive the global bipolar disorder market growth. For instance, in February 2019, Otsuka Holdings Co. Ltd. reported Phase III clinical trial evaluation of brexpiprazole for the treatment of manic attacks in bipolar disorder I. The study was conducted to confirm the effectiveness of brexpiprazole for a duration of 2-3 weeks, in double-blind and placebo-controlled trials. It was found that the drug was well tolerated by the patients.

Furthermore, in July 2018, a team of researchers from Novartis International AG studied on digital measurement tools for bipolar disorders so that accurate drug can be given for an effective treatment. Until now, these disorders are identified by conventional methods and no definitive tool is available, which tests the spinal fluid present in the brain. According to the researchers, these digital measurement tools may help in diagnosis of bipolar disorder and will increase the efficacy of drugs.

Moreover, intervention of medical adherence tools (such as electronic adherence monitoring devices) to increase treatment adherence in patients with bipolar disorders may improve outcomes in the treatment of bipolar disorder patients. It ensures that medication is properly taken and it is done so by ways such as psychoeducational and family communication interventions, cognitive behavior therapy, manipulating the packaging of the drugs, simplifying a dosage regimen with pill boxes, medication organizers, blister packaging, or coordinating dosage times with the daily activities of patients.

Therefore, increasing research and development of novel tools for diagnosis of bipolar disorders is expected to support the global bipolar disorders treatment market growth over the forecast period.

Global Bipolar Disorders Treatment Market Regional Analysis

North America is expected to hold dominant position in the global bipolar disorder treatment market. Presence of leading manufacturers such as Eli Lilly and Co., Pfizer Inc., and AbbVie Inc in the region has supported North America bipolar disorders treatment market. Moreover, ongoing research and development in bipolar disorder treatments by companies such as Sage Therapeutics is expected to support North America bipolar disorders treatment market growth over the forecast period. For instance, Sage Therapeutics is working on Sage-217 drug for major depressive episode of bipolar disorder. The drug has completed phase-II of clinical trials in March 2019. Such key developments are expected to boost the global bipolar disorder treatment market growth.

Furthermore, key players from other markets have also received approvals for their novel products in the U.S. For instance, Allergan (Ireland-based company) received Supplemental New Drug Application (sNDA) expansion on Varylar in 2017, which aids in the treatment of bipolar disorders.

Moreover, increasing initiatives from various governments and organizations to spread awareness regarding mental health also supports the global bipolar disorders treatment market growth. For instance, Mental Health America celebrates the month of May as the Mental Awareness Month. The organization offers various other organizations a toolkit designed for the patients with chronic conditions. These factors are expected to support global bipolar disorders treatment market growth over the forecast period.

Global Bipolar Disorders Treatment Market Restraints

Side effects related with drugs used in the treatment of bipolar disorders is expected to negatively affect adoption of these drugs, thereby hindering the lobal bipolar disorder treatment market growth. For instance, in July 2018, Icahn School of Medicine at Mount Sinai in New York conducted a study on pregnant women suffering from bipolar disorder to evaluate lithium drug, which is used as mood stabilizer. The study found that infants of these pregnant women were born with congenital disease. Such side effects of drugs can obstruct the global bipolar disorder treatment market growth.

Global Bipolar Disorders Treatment Market Key Players

Some of the major players operating in the global bipolar disorder treatment market include, Pfizer Inc., Eli Lilly and Co, Apotex Technology Inc., AbbVie Inc., Novartis AG, Otsuka holdings co. Ltd., GlaxoSmithKline LLC, AstraZeneca, Allergan plc., and Janssen Pharmaceuticals Inc.

Global Bipolar Disorders Treatment Market Taxonomy

The global bipolar disorders treatment market is segmented on the basis of drug class, route of administration, distribution channel, and regions. 

By Drug Class:

  • Mood stabilizers
  • Lithium
  • Antipsychotics
  • Aripiprazole
  • Olanzapine
  • Quetiapine
  • Paliperidone
  • Antidepressants
  • Citalopram
  • Escitalopram
  • Fluoxetine
  • Paroxetine
  • Sertraline
  • Anticonvulsant
  • Valproate
  • Carbamazepine
  • Lamotrigine
  • Others

By Route of Administration:

  • Oral
  • Intramuscular
  • Intravenous

By Distribution Channel:

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.
Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.